、Retirement Of Treasury Stock、未払費用他1件
- 【期間】
年度 | | Retirement Of Treasury Stock | 未払費用 | 研究開発費 - 医薬 |
---|
2008/12 | - | | - | | 1166億 | | - | |
2009/12 | - | | - | | 1055億 | -9.5% | - | |
2010/12 | - | | - | | 882億 | -16.4% | - | |
2011/12 | - | | - | | 924億 | +4.8% | - | |
2012/12 | - | | - | | 1012億 | +9.5% | - | |
2013/12 | - | | - | | 1148億 | +13.4% | - | |
2014/12 | -2681億 | | - | | 1322億 | +15.2% | - | |
2015/12 | - | | - | | 1205億 | -8.9% | - | |
2016/12 | - | | - | | 1192億 | -1.1% | - | |
2017/12 | - | | - | | 18.7億 | -98.4% | - | |
2018/12 | - | | - | | 5.72億 | -69.4% | - | |
2019/12 | - | | - | | 18.7億 | +227.6% | 532億 | |
2020/12 | - | | - | | 10.5億 | -44.2% | 520億 | -2.3% |
2021/12 | - | | - | | 11.1億 | +6.5% | 574億 | +10.4% |
2022/12 | - | | - | | 15.9億 | +42.7% | 624億 | +8.7% |
2023/12 | - | | - | | 22.4億 | +41.3% | 718億 | +15.1% |